Peter Maag - Feb 1, 2023 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Reginald Seeto, as attorney-in-fact for Peter Maag
Stock symbol
CDNA
Transactions as of
Feb 1, 2023
Transactions value $
-$85,830
Form type
4
Date filed
2/3/2023, 08:46 PM
Previous filing
Jan 9, 2023
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Award $0 +5.23K +1.75% $0.00 304K Feb 1, 2023 Direct F1
transaction CDNA Common Stock Sale -$85.8K -5K -1.65% $17.17 299K Feb 2, 2023 Direct F2, F3
holding CDNA Common Stock 1K Feb 1, 2023 As UTMA custodian for minor child F4
holding CDNA Common Stock 1K Feb 1, 2023 As UTMA custodian for minor child F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were subject to a performance restricted stock unit award that was initially granted on February 3, 2021 for a two-year performance period over calendar years 2021 and 2022, which performance was assessed and finalized effective February 1, 2023. 50.00% of the reported securities vested on February 1, 2023 and 50% of the reported securities will vest on December 31, 2023, subject to the Reporting Person's continued service with the Issuer.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.08 to $17.285, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.